<SEC-DOCUMENT>0001387131-22-009901-index.html : 20220920
<SEC-HEADER>0001387131-22-009901.hdr.sgml : 20220920
<ACCEPTANCE-DATETIME>20220920170637
ACCESSION NUMBER:		0001387131-22-009901
CONFORMED SUBMISSION TYPE:	10-K/A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220920
DATE AS OF CHANGE:		20220920

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adamis Pharmaceuticals Corp
		CENTRAL INDEX KEY:			0000887247
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				820429727
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36242
		FILM NUMBER:		221254408

	BUSINESS ADDRESS:	
		STREET 1:		11682 EL CAMINO REAL
		STREET 2:		SUITE 300
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		(858) 997-2400

	MAIL ADDRESS:	
		STREET 1:		11682 EL CAMINO REAL
		STREET 2:		SUITE 300
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CELLEGY PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19950615
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K/A
<SEQUENCE>1
<FILENAME>admp-10ka_123121.htm
<DESCRIPTION>AMENDMENT NO. 2 TO FORM 10-K
<TEXT>
Document 1 - file: admp-10ka_123121.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>ex31-1.htm
<DESCRIPTION>CERTIFICATION BY CEO PURSUANT TO SECTION 302
<TEXT>
Document 2 - file: ex31-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>ex31-2.htm
<DESCRIPTION>CERTIFICATION BY CFO PURSUANT TO SECTION 302
<TEXT>
Document 3 - file: ex31-2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>ex32-1.htm
<DESCRIPTION>CERTIFICATION BY CEO PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
<TEXT>
Document 4 - file: ex32-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>ex32-2.htm
<DESCRIPTION>CERTIFICATION BY CFO PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
<TEXT>
Document 5 - file: ex32-2.htm

</DOCUMENT>
</SEC-DOCUMENT>